Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Johns Hopkins University
Age
6–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 6 to 18 years
Diagnosis of ADHD
A score of at least 3 (mildly ill) on the clinician administered Clinical Global Impressions-Severity (CGI-S)
You may not be if
Currently taking stimulant medications (within one week of first study visit). Patients will not be asked to discontinue any treatments for the purpose of this research study. Subjects will include treatment naïve patients and patients who were previously treated with stimulant medications, but are not currently treated, and meet study criteria.
Having an adverse reaction to methylphenidate, or other stimulant medication
Current psychiatric disorder, including bipolar I or II disorder, major depressive, disorder, obsessive-compulsive disorder, autism spectrum disorder, Tourette syndrome, or history of psychosis
Patient is at risk for clinically significant deterioration due to study protocol, as assessed by primary medical investigator (Dr. Grant)
Confirmed genetic disorder with cognitive and/or behavioral disturbances
Active, unstable medical illness that may interfere with cognition or compromises safety of the patient
History of head trauma with loss of consciousness or any evidence of functional impairment due to, and persisting after, head trauma
Neurological disorder, mental retardation, intellectual or disability, or other non-ADHD cause of cognitive impairment
Pregnant or breast-feeding women
Having a contraindication to MRI, including a pacemaker, defibrillator or other medical implant, other metal objects, or claustrophobia, or for having braces or other metal in the head region (likely to create an artifact on the MRI scans).
Currently smoking or using controlled or illicit substances, including alcohol.
